BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$903M |
| 2 |
Apple
AAPL
|
+$854M |
| 3 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$771M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$696M |
| 5 |
Oracle
ORCL
|
+$621M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$1.55B |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$976M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$928M |
| 4 |
AET
Aetna Inc
AET
|
+$832M |
| 5 |
KITE
Kite Pharma, Inc.
KITE
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.45% |
| 2 | Technology | 14.96% |
| 3 | Healthcare | 12.92% |
| 4 | Industrials | 10.26% |
| 5 | Consumer Discretionary | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KERX
2601
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $28.4M | ﹤0.01% |
6,097,948
+112,381
| +2% | +$619K |
|
|
APTI
2602
DELISTED
Apptio, Inc. Class A Common Stock
APTI
| $28.3M | ﹤0.01% |
1,204,663
-18,076
| -1% | -$384K |
|
2603
Orion Group Holdings
ORN
$419M
| $28.3M | ﹤0.01% |
3,613,061
+31,520
| +0.9% | +$234K |
|
2604
Celldex Therapeutics
CLDX
$3.27B
| $28.2M | ﹤0.01% |
662,047
+18,619
| +3% | +$798K |
|
2605
Bristow Group
VTOL
$1.35B
| $28.2M | ﹤0.01% |
1,310,192
+77,569
| +6% | +$1.63M |
|
2606
Coherus Oncology
CHRS
$210M
| $28.1M | ﹤0.01% |
3,198,726
-79,323
| -2% | -$849K |
|
2607
NVE Corp
NVEC
$620M
| $28.1M | ﹤0.01% |
326,763
-2,164
| -0.7% | -$182K |
|
|
FBR
2608
DELISTED
Fibria Celulose Sa
FBR
| $28.1M | ﹤0.01% |
1,909,585
+343,519
| +22% | +$5.22M |
|
2609
VSE Corp
VSEC
$6.07B
| $28M | ﹤0.01% |
579,198
+11,719
| +2% | +$601K |
|
2610
Bassett Furniture
BSET
$176M
| $28M | ﹤0.01% |
745,137
+15,259
| +2% | +$585K |
|
2611
TG Therapeutics
TGTX
$7.63B
| $28M | ﹤0.01% |
3,414,999
+115,252
| +3% | +$1.01M |
|
2612
PUT
Walt Disney
DIS
$181B
| $27.9M | ﹤0.01% |
+259,500
| New | +$26.7M |
|
2613
Ecopetrol
EC
$34.1B
| $27.6M | ﹤0.01% |
1,884,744
-639,655
| -25% | -$7.34M |
|
|
GNBC
2614
DELISTED
Green Bancorp, Inc
GNBC
| $27.5M | ﹤0.01% |
1,356,236
-57,869
| -4% | -$1.28M |
|
2615
Inovio Pharmaceuticals
INO
$67.2M
| $27.4M | ﹤0.01% |
552,292
-4,963
| -0.9% | -$308K |
|
|
COWN
2616
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $27.3M | ﹤0.01% |
2,002,520
+80,481
| +4% | +$1.21M |
|
|
TBHC
2617
DELISTED
The Brand House Collective
TBHC
| $27.3M | ﹤0.01% |
2,278,912
+160,233
| +8% | +$1.96M |
|
|
ELGX
2618
DELISTED
Endologix Inc
ELGX
| $27.2M | ﹤0.01% |
509,305
+5,675
| +1% | +$300K |
|
|
SOHU
2619
Sohu.com
SOHU
$355M
| $27.2M | ﹤0.01% |
627,641
-276,632
| -31% | -$14.8M |
|
2620
AppFolio
APPF
$6.98B
| $27.2M | ﹤0.01% |
655,395
+122,715
| +23% | +$5.5M |
|
2621
Ares Capital
ARCC
$14.4B
| $27.2M | ﹤0.01% |
1,727,243
+124,492
| +8% | +$2.02M |
|
2622
Hamilton Lane
HLNE
$5.58B
| $27.1M | ﹤0.01% |
765,182
+23,002
| +3% | +$709K |
|
|
NVEE
2623
DELISTED
NV5 Global
NVEE
| $27.1M | ﹤0.01% |
1,998,432
+146,044
| +8% | +$1.98M |
|
|
TVRD
2624
Tvardi Therapeutics
TVRD
$23.4M
| $27M | ﹤0.01% |
61,317
+12,482
| +26% | +$5.69M |
|
|
KDNY
2625
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $27M | ﹤0.01% |
720,244
-11,600
| -2% | -$506K |
|
Similar funds
BlackRock's Q4 2017 Portfolio in Review
As of Q4 2017, BlackRock held 5,151 positions worth $2.1T, up 6.1% from $1.98T the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BlackRock's Q4 2017 filing shows 147 new, 3,054 increased, 1,214 reduced and 177 closed positions. Its largest new stake was iShares Core MSCI International Developed Markets ETF: 13,434,810 shares worth $786M. The largest sale was CR Bard Inc., an estimated $1.55B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- BlackRock's largest Q4 2017 buy was iShares Core MSCI International Developed Markets ETF: 13,434,810 shares worth $786M.
- BlackRock added most to Meta Platforms (Facebook) in Q4 2017, an estimated $903M increase.
- BlackRock's biggest Q4 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $928M.
- BlackRock fully exited CR Bard Inc. in Q4 2017, selling an estimated $1.55B.
- BlackRock's ten largest holdings make up 13% of its $2.1T portfolio in Q4 2017.
- BlackRock opened 147 new positions and closed 177 in Q4 2017.
- BlackRock's portfolio value rose 6.1% quarter-over-quarter to $2.1T.
Based on BlackRock's 13F filing for Q4 2017, filed 9 Feb 2018.